Company Description
McKesson moves medicine. The largest pharmaceuticals distributor in the US, McKesson delivers prescription and generic drugs, as well as health...
Key McKesson Financials
| Company Type | Public - NYSE: MCK Main Headquarters |
|---|---|
| Fiscal Year-End | March |
| 2007 Sales (mil.) | $92,977.0 |
| 2007 Employees | 31,800 |
More McKesson Financials (11 pages)
Latest McKesson Jobs powered by Monster.com
- Account Manager - Inside Sales
- Accountant
- Customer Service Rep
Rankings
- #18 in FORTUNE 500
- S&P 500
Competition
Competitive Landscape for Computer Software Development
The US economy heavily influences business spending for software products. The success of programming companies depends heavily on strong technical expertise. The success of packaged-software...
Read more about McKesson's competition across multiple industries
Top McKesson Competitors
Sponsored Links
The Business DirectoryMcKesson Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman, President, and CEO | John H. Hammergren | Network | E-mail |
| EVP and Group President; President, McKesson Supply Solutions | Paul C. Julian | Network | E-mail |
| EVP and CFO | Jeffrey C. Campbell | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Current McKesson News
- McKesson Corp(Alt Est) (MCK.AL) Weekly Earnings Information [Nelson Information - Weekly Domestic] (11 May 2008 05:46:00 EDT)
- McKesson Corp(EBITDA) (MCK.EB) Weekly Earnings Information [Nelson Information - Weekly Domestic] (11 May 2008 05:46:00 EDT)
- McKesson Corp(GAAP) (MCK.GP) Weekly Earnings Information [Nelson Information - Weekly Domestic] (11 May 2008 02:19:00 EDT)
Latest Industry Video
-
ASCO 2007 Preview (5:07)
06/01/07 8:50AM ET - Wachovia Capital Markets Senior Biotech Analyst George Farmer and Miller Tabak Pharmaceutical Analyst Les Fundleyder discuss new drugs coming out at this year's conference.






